Second RSV Vaccine Lands Approval for Older Adults

(MedPage Today) -- The FDA has approved a second respiratory syncytial virus (RSV) vaccine for preventing lower respiratory infections in adults 60 and over, Pfizer announced on Wednesday. Approval of the unadjuvanted, bivalent RSV prefusion F...
Source: MedPage Today Public Health - Category: American Health Source Type: news